Evidence map›Paper›PMID 24416260›Full record

ArticlePloS one2014

Altered mitochondria morphology and cell metabolism in Apaf1-deficient cells.

Mónica Sancho, Anna Gortat, Andrés E Herrera, Vicente Andreu-Fernández, Elisabetta Ferraro, Francesco Cecconi, Mar Orzáez, Enrique Pérez-Payá

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Intercellular mRNA trafficking via membrane nanotube-like extensions in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  6. Article
  7. Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth.Cellular and molecular life sciences : CMLS · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mónica SanchoLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Anna GortatLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Andrés E HerreraLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Vicente Andreu-FernándezLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Elisabetta FerraroLaboratory of Skeletal Muscle Development and Metabolism, IRCCS San Raffaele Pisana Institute, Rome, Italy.
Francesco CecconiLaboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, Rome, Italy ; Dulbecco Telethon Institute, University of Rome 'Tor Vergata', Rome, Italy.
Mar OrzáezLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain.
Enrique Pérez-PayáLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain ; Instituto de Biomedicina de Valencia, IBV-CSIC, Valencia, Spain.
Centro de Investigacion Principe Felipe · ESFondazione Santa Lucia · ITIstituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Funding

Telethon TCR04004
6 · The paper itself

Abstract

backgroundApaf1 (apoptotic protease activating factor 1) is the central component of the apoptosome, a multiprotein complex that activates procaspase-9 after cytochrome c release from the mitochondria in the intrinsic pathway of apoptosis. Other cellular roles, including a pro-survival role, have also been described for Apaf1, while the relative contribution of each function to cell death, but also to cell homeostatic conditions, remain to be clarified. METHODOLOGY AND PRINCIPAL

findingsHere we examined the response to apoptosis induction of available embryonic fibroblasts from Apaf1 knockout mice (MEFS KO Apaf1). In the absence of Apaf1, cells showed mitochondria with an altered morphology that affects cytochrome c release and basal metabolic status.

conclusionsWe analysed mitochondrial features and cell death response to etoposide and ABT-737 in two different Apaf1-deficient MEFS, which differ in the immortalisation protocol. Unexpectedly, MEFS KO Apaf1 immortalised with the SV40 antigen (SV40IM-MEFS Apaf1) and those which spontaneously immortalised (SIM-MEFS Apaf1) respond differently to apoptotic stimuli, but both presented relevant differences at the mitochondria when compared to MEFS WT, indicating a role for Apaf1 at the mitochondria.

Indexed as

AnimalsApoptotic Protease-Activating Factor 1Basal MetabolismCell DeathCytochromes cGene Knockout TechniquesHeLa CellsHumansMiceMitochondriaAPAF1 protein, humanApaf1 protein, mouseApoptotic Protease-Activating Factor 1Cytochromes c

Identifiers

PMID24416260
PMCPMC3886985
OpenAlexW2140106809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.